Cascade Technologies Corp.
| OTC Markets: CSDT
Cascade Technologies Corp. operates as a development stage, medical imaging device company. The firm conducts its medical device operations through its wholly-owned subsidiary, Spectral Molecular Imaging, Inc., which develops non-invasive devices and uses its patented technology for improved clinical diagnostics and operate in conjunction with surgical and/or evaluation procedures in real time. Its products include EndoSpect, OxySpect and SkinSpect. The company was founded by Daniel L. Farkas on July 16, 2004 and is headquartered in Beverly Hills, CA.